Filing metadata

Accession number
0001610520-24-000151
Form type
Form 4
Filer
ENDRA Life Sciences Inc.
CIK
CIK 1681682
Filed
Aug 29, 2024
Reporting period
Aug 27, 2024
Description
Insider transaction

Explore SEC Filings Hub